To address the current national emergency, U.S. entities may be eligible to license select Sandia intellectual property at no cost for a limited time. Learn more.

Search/Browse Tech

Microfluidic platform for multiplexed detection in single cells and methods thereof

GO BACK

United States Patent

To discuss licensing opportunities, fill out our Contact Form 
10,731,205
August 4, 2020
View the Complete Patent at the US Patent & Trademark Office
The present invention relates to a microfluidic device and platform configured to conduct multiplexed analysis within the device. In particular, the device allows multiple targets to be detected on a single-cell level. Also provided are methods of performing multiplexed analyses to detect one or more target nucleic acids, proteins, and post-translational modifications.
15/925,389
March 19, 2018
1/1;
C12Q 1/6837 (20180101); C12Q 1/6816 (20180101); G01N 15/14 (20060101); C40B 30/04 (20060101); G01N 15/10 (20060101); B01L 3/00 (20060101); G01N 33/536 (20060101); C12Q 1/6841 (20180101); C12Q 1/6804 (20180101); C12Q 1/6844 (20180101);
STATEMENT OF GOVERNMENT INTEREST This invention was made with Government support under Contract No. DE-NA0003525 awarded by the United States Department of Energy/National Nuclear Security Administration. The Government has certain rights in the invention.